"Karyotyping" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Mapping of the KARYOTYPE of a cell.
| Descriptor ID |
D007621
|
| MeSH Number(s) |
E01.370.225.500.385.315 E05.200.500.385.315 E05.242.385.315 E05.393.285.475
|
| Concept/Terms |
Karyotyping- Karyotyping
- Karyotypings
- Karyotype Analysis Methods
- Analysis Method, Karyotype
- Analysis Methods, Karyotype
- Karyotype Analysis Method
- Method, Karyotype Analysis
- Methods, Karyotype Analysis
|
Below are MeSH descriptors whose meaning is more general than "Karyotyping".
Below are MeSH descriptors whose meaning is more specific than "Karyotyping".
This graph shows the total number of publications written about "Karyotyping" by people in this website by year, and whether "Karyotyping" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 5 | 5 |
| 1995 | 0 | 4 | 4 |
| 1996 | 0 | 3 | 3 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 5 | 5 |
| 1999 | 1 | 2 | 3 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 5 | 5 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 4 | 4 |
| 2004 | 1 | 8 | 9 |
| 2005 | 0 | 5 | 5 |
| 2006 | 0 | 3 | 3 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 2 | 2 |
| 2009 | 0 | 4 | 4 |
| 2010 | 0 | 9 | 9 |
| 2011 | 0 | 3 | 3 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2014 | 3 | 3 | 6 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
| 2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Karyotyping" by people in Profiles.
-
The first post-natal clinical description of true mosaic complete tetrasomy 21: A case report. Am J Med Genet A. 2021 11; 185(11):3507-3509.
-
The genetic landscape of intellectual disability and epilepsy in adults and the elderly: a systematic genetic work-up of 150 individuals. Genet Med. 2021 08; 23(8):1492-1497.
-
Variability in Cytogenetic Testing for Multiple Myeloma: A Comprehensive Analysis From Across the United States. JCO Oncol Pract. 2020 10; 16(10):e1169-e1180.
-
Miscarriage chromosome testing: Indications, benefits and methodologies. Semin Perinatol. 2019 03; 43(2):101-104.
-
Yield of additional genetic testing after chromosomal microarray for diagnosis of neurodevelopmental disability and congenital anomalies: a clinical practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med. 2018 10; 20(10):1105-1113.
-
De novo unbalanced translocation (4p duplication/8p deletion) in a patient with autism, OCD, and overgrowth syndrome. Am J Med Genet A. 2017 Jun; 173(6):1656-1662.
-
Immunohistochemistry for p53 is a useful tool to identify cases of acute myeloid leukemia with myelodysplasia-related changes that are TP53 mutated, have complex karyotype, and have poor prognosis. Mod Pathol. 2017 03; 30(3):382-392.
-
Prognostic and biologic significance of DNMT3B expression in older patients with cytogenetically normal primary acute myeloid leukemia. Leukemia. 2015 Mar; 29(3):567-75.
-
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology Group. Pediatr Dev Pathol. 2014 Nov-Dec; 17(6):441-9.
-
Acute myeloid leukemia with monosomal karyotype: morphologic, immunophenotypic, and molecular findings. Am J Clin Pathol. 2014 Aug; 142(2):190-5.